GSA Capital Partners’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$359K	Buy	298,881 +85,236	+40%	+$104K	0.02%	1134
2025 Q4	$210K	Sell	213,645 -97,181	-31%	-$117K	0.02%	1382
2025 Q3	$392K	Buy	310,826 +54,104	+21%	+$58.3K	0.03%	1021
2025 Q2	$288K	Buy	+256,722	New	+$298K	0.02%	1283
2024 Q3	–	Sell	-264,467	Closed	-$867K	–	1724
2024 Q2	$867K	Buy	264,467 +212,188	+406%	+$929K	0.06%	598
2024 Q1	$384K	Buy	52,279 +9,276	+22%	+$57.4K	0.03%	1066
2023 Q4	$161K	Sell	43,003 -210,426	-83%	-$497K	0.01%	1363
2023 Q3	$537K	Buy	253,429 +59,019	+30%	+$196K	0.05%	748
2023 Q2	$925K	Sell	194,410 -16,000	-8%	-$88.3K	0.09%	356
2023 Q1	$1.2M	Buy	210,410 +151,978	+260%	+$917K	0.12%	231
2022 Q4	$590K	Buy	+58,432	New	+$1.1M	0.07%	502